BeckmanA. L., BilinskiA., BoykoR., CampG. M., WallA. T., LimJ. K., WangE. A., BruceR. D., & GonsalvesG. S. (2016). New hepatitis C drugs are very costly and unavailable to many state prisoners. Health Affairs, 35(10), 1893–1901. 10.1377/hlthaff.2016.0296
2.
EssienU. R., DusetzinaS. B., & GelladW. F. (2021). A policy prescription for reducing health disparities-Achieving pharmacoequity. JAMA, 326(18), 1793–1794. 10.1001/jama.2021.17764
